Trial Details
WITHDRAWNBasic Information
| Clinical ID | c2929 |
|---|---|
| Identifier | NCT02769494 |
| Trial Title | The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Oral Ulcer |
| Interventions | DRUG: Mesalazine Sustained-Release Tablets|DRUG: Riboflavin Sodium Phosphate Injection |
Participant Information
| Sponsor | Xijing Hospital of Digestive Diseases |
|---|---|
| City | Shaanxi |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2016-03 |
|---|---|
| Primary Completion Date | 2016-12 |
| Completion Date | 2017-01 |